Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Bader, Michael Prof. Dr. (3) Daumke, Oliver Prof. Dr. (1) Geisberger, Sabrina Yasmin Dr. (1) Haase, Nadine Dr. (4) Herse, Florian PD Dr. (7) Hinze, Christian Dr. med. Dipl.-Math. (1) Hübner, Norbert Prof. Dr. (1) Kempa, Stefan Dr. (1) Luft, Friedrich Prof. Dr. (15) Müller, Dominik Prof. Dr. (22) Niendorf, Thoralf Prof. Dr. (1) Popova, Elena Dr. (1) Qadri, Fatimunnisa Dr. (1) Wallukat, Gerd Dr. (4) Wilck, Nicola Dr. med. (1) (-) Dechend, Ralf Priv. Doz. (21) (-) Scheidereit, Claus Prof. Dr. (1) 1999 (1) 2000 (5) (-) 2001 (6) 2002 (7) 2003 (3) 2004 (3) 2005 (8) 2006 (1) 2007 (6) 2008 (11) 2009 (12) 2010 (9) 2011 (11) 2012 (16) 2013 (16) 2014 (18) (-) 2015 (15) 2016 (20) 2017 (16) 2018 (11) 2019 (16) 2020 (19) 2021 (13) 2022 (11) 2023 (11) 2024 (2) AG Müller/Dechend (ECRC) (21) Angiogenesis & Metabolism Laboratory (1) Biology of Malignant Lymphomas (1) Cancer Genetics and Cellular Stress Responses (1) Cellular Neurosciences (37) Genetics and Genomics of Cardiovascular Diseases (1) Hypertension-caused End-Organ Damage (21) (-) Hypertension-Mediated End-Organ Damage (21) Immune Regulation and Cancer (1) Integrative Vascular Biology (10) Mathematical Modelling of Cellular Processes (1) Molecular Biology of Peptide Hormones (3) Protein Production and Characterization (1) Proteomics and Metabolomics (1) Psychoneuroimmunology (5) RNA Biology and Posttranscriptional Regulation (1) Structural Biology of Membrane-Associated Processes (1) 21 Results: Active Filter: Dechend, Ralf Priv. Doz.Scheidereit, Claus Prof. Dr.Hypertension-Mediated End-Organ Damage20012015 Sort: Result score Newest to oldest Oldest to newest January 01, 2001 / Am J Hypertens Modulating angiotensin II-induced inflammation by HMG Co-A reductase inhibition R. Dechend A. Fiebler C. Lindschau H. Bischoff D.N. Mueller J.K. Park R. Dietz H. Haller F.C. Luft January 01, 2001 / FASEB J Aspirin inhibits NF-kappa B and protects from angiotensin II-induced organ damage D.N. Mueller V. Heissmeyer R. Dechend F. Hampich J.K. Park A. Fiebeler E. Shagdarsuren J. Theuer M. Elger B. Pilz V. Breu K. Schroer D. Ganten R. Dietz H. Haller C. Scheidereit F.C. Luft January 01, 2001 / Circulation Amelioration of angiotensin II-induced cardiac injury by a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor R. Dechend A. Fiebeler J.K. Park D.N. Muller J. Theuer E. Mervaala M. Bieringer D. Gulba R. Dietz F.C. Luft H. Haller January 01, 2001 / Adv Nephrol Necker Hosp Angiotensin-induced inflammation and novel approaches to treatment D.N. Mueller R. Dechend A. Fiebeler J.K. Park H. Haller F.C. Luft January 01, 2001 / Hypertension Mineralocorticoid receptor affects AP-1 and nuclear factor-kappa B activation in angiotensin II-induced cardiac injury A. Fiebeler F. Schmidt D.N. Mueller J.K. Park R. Dechend M. Bieringer E. Shagdarsuren V. Breu H. Haller F.C. Luft April 01, 2001 / Contrib Nephrol Angiotensin-induced inflammation and vascular injury D.N. Mueller R. Dechend A. Fiebeler J.K. Park H. Haller F.C. Luft February 01, 2015 / Am J Hypertens Progression of kidney injury and cardiac remodeling in obese spontaneously hypertensive rats: the role of renal sympathetic innervation D. Linz M. Hohl J. Schuetze F. Mahfoud T. Speer B. Linz T. Hübschle H.P. Juretschke R. Dechend J. Geisel H. Rütten M. Böhm January 01, 2015 / Cell Mol Life Sci A potential pathophysiological role for galectins and the renin-angiotensin system in preeclampsia S.M. Blois R. Dechend G. Barrientos A.C. Staff May 01, 2015 / J Hum Hypertens The impact of age on the benefits and risks of aliskiren treatment: analyses of the 3A registry S. Friedrich U. Zeymer R. Dechend I. Hagedorn T. Riemer C. Zemmrich P. Bramlage D. Pittrow J. Senges R.E. Schmieder February 01, 2015 / J Am Heart Assoc Vitamin D depletion aggravates hypertension and target-organ damage L.B. Andersen L. Przybyl N. Haase F. von Versen-Höynck F. Qadri J.S. Jørgensen G.L. Sorensen P. Fruekilde M. Poglitsch I. Szijártó M. Gollasch J. Peters D.N. Muller H.T. Christesen R. Dechend Pagination Current page 1 Page 2 Page 3 Next page Next › Last page Last »
January 01, 2001 / Am J Hypertens Modulating angiotensin II-induced inflammation by HMG Co-A reductase inhibition R. Dechend A. Fiebler C. Lindschau H. Bischoff D.N. Mueller J.K. Park R. Dietz H. Haller F.C. Luft
January 01, 2001 / FASEB J Aspirin inhibits NF-kappa B and protects from angiotensin II-induced organ damage D.N. Mueller V. Heissmeyer R. Dechend F. Hampich J.K. Park A. Fiebeler E. Shagdarsuren J. Theuer M. Elger B. Pilz V. Breu K. Schroer D. Ganten R. Dietz H. Haller C. Scheidereit F.C. Luft
January 01, 2001 / Circulation Amelioration of angiotensin II-induced cardiac injury by a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor R. Dechend A. Fiebeler J.K. Park D.N. Muller J. Theuer E. Mervaala M. Bieringer D. Gulba R. Dietz F.C. Luft H. Haller
January 01, 2001 / Adv Nephrol Necker Hosp Angiotensin-induced inflammation and novel approaches to treatment D.N. Mueller R. Dechend A. Fiebeler J.K. Park H. Haller F.C. Luft
January 01, 2001 / Hypertension Mineralocorticoid receptor affects AP-1 and nuclear factor-kappa B activation in angiotensin II-induced cardiac injury A. Fiebeler F. Schmidt D.N. Mueller J.K. Park R. Dechend M. Bieringer E. Shagdarsuren V. Breu H. Haller F.C. Luft
April 01, 2001 / Contrib Nephrol Angiotensin-induced inflammation and vascular injury D.N. Mueller R. Dechend A. Fiebeler J.K. Park H. Haller F.C. Luft
February 01, 2015 / Am J Hypertens Progression of kidney injury and cardiac remodeling in obese spontaneously hypertensive rats: the role of renal sympathetic innervation D. Linz M. Hohl J. Schuetze F. Mahfoud T. Speer B. Linz T. Hübschle H.P. Juretschke R. Dechend J. Geisel H. Rütten M. Böhm
January 01, 2015 / Cell Mol Life Sci A potential pathophysiological role for galectins and the renin-angiotensin system in preeclampsia S.M. Blois R. Dechend G. Barrientos A.C. Staff
May 01, 2015 / J Hum Hypertens The impact of age on the benefits and risks of aliskiren treatment: analyses of the 3A registry S. Friedrich U. Zeymer R. Dechend I. Hagedorn T. Riemer C. Zemmrich P. Bramlage D. Pittrow J. Senges R.E. Schmieder
February 01, 2015 / J Am Heart Assoc Vitamin D depletion aggravates hypertension and target-organ damage L.B. Andersen L. Przybyl N. Haase F. von Versen-Höynck F. Qadri J.S. Jørgensen G.L. Sorensen P. Fruekilde M. Poglitsch I. Szijártó M. Gollasch J. Peters D.N. Muller H.T. Christesen R. Dechend